![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 241/20 | |
A61K 31/4965 | |||
A61P 9/10 |
(11) | Number of the document | 3344607 |
(13) | Kind of document | T |
(96) | European patent application number | 16766424.2 |
Date of filing the European patent application | 2016-09-02 | |
(97) | Date of publication of the European application | 2018-07-11 |
(45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/050021 |
Date | 2016-09-02 |
(87) | Number | WO 2017/040872 |
Date | 2017-03-09 |
(30) | Number | Date | Country code |
201562213702 P | 2015-09-03 | US | |
201562250955 P | 2015-11-04 | US | |
201662343617 P | 2016-05-31 | US |
(72) |
VILLALVA, Nidia, MX
CANTE, Ivon, MX
AYBAR, Martin, MX
RODRIGUEZ, Angel, MX
TORRES, Alejandro, Guillen, MX
KANTOR, Hana, CZ
GAVENDA, Ales, CZ
HERRERA, Hugo, MX
JEGOROV, Alexander, CZ
LOPEZ, Nydia, MX
|
(73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Jona,
CH
|
(54) | SOLID STATE FORMS OF SELEXIPAG |
SOLID STATE FORMS OF SELEXIPAG |